Echo Therapeutics is an Australian Pharmaceutical and Medical Technology Company, specialising in branded products and unique services for the hospital sector in Australia and New Zealand.

Echo Therapeutics

Echo Therapeutics ANZ | 363 followers on LinkedIn. Partnering for success: Multinational quality, boutique service for patients, payers and partners | Echo Therapeutics is a newly-formed Australian pharmaceutical and medical technology company for the ANZ hospital sector. 

Realising untapped value for you by connecting patient insights to your needs.

Having a meaningful impact on patients’ lives by partnering with global and local groups, we will “echo” their brands in our markets to build value for our customers to enable a better patient experience.

Medical Manager at Echo Therapeutics ANZ

Erik Teh

Echo Therapeutics ANZ

A single spark can ignite a flame of change – and Echo Therapeutics is proud to be part of that spark! Echo Therapeutics ANZ is thrilled to announce that we'll be part of the Advanced Pharmacy Australia - Medicines Management 2024 Conference in Adelaide beginning today. Visit the team at Stand 12 in the exhibition hall to connect, collaborate, and join us on the mission to illuminate new ways of thinking in pharma. 🙏 https://lnkd.in/gZ2mAhvF #Pharmacy #hospital #partnerships #collaboration #echotherapeuticsanz

Reposting this to our LinkedIn Echo Therapeutics ANZ friends to see if anyone that is available to lend a hand to Chronic Pain Australia and volunteer in the Lismore NSW region 🤝 see the post below for more info..

The Echo Therapeutics ANZ team was delighted to attend the #2024 Australian Society of Anaesthetists ' National Scientific Conference in Darwin last week, to connect and reconnect with delegates from the #ASA . It was great to attend the #ASA plenary and sessions on the management of acute pain and hear from delegates about their real-world challenges, and their commitment to supporting responsible pain management post surgery. The team also had some opportunities to meet some 'locals' and enjoy some team downtime as well. Echo Therapeutics ANZ #ASA

Echo Therapeutics ANZ was proud to host the Cancer Council Australia initiative for Australia's Biggest Morning Tea event yesterday! The annual event raises awareness on the impact of cancer research, support, and prevention. One in two of us will have a cancer diagnosis by 85 years. Every one of us has been touched directly or by someone we know with a cancer diagnosis. As an ex-oncology nurse this is very important to me personally. We were joined by the #Echo team, family, friends and dignitaries like the Federal member for Bradfield Senator Paul Fletcher and my friend and ex-colleague Medical Oncologist Dr David Bell. Echo Therapeutics products have treated >250,000 cancer patients in the last year alone, across cancer areas including: breast; bowel; lymphomas and myeloproliferative neoplasms. Every contribution makes a difference, and with our target initially set at $1,000, we managed to raise over $3,000. If you would like to contribute to this worthy cause, feel free to donate at @ https://lnkd.in/gqYYJfAr

Echo Therapeutics ANZ is delighted to announce our new strategic partnership 🤝 with Pharmanovia , to promote its Pain/CNS portfolio and selected products within the endocrinology portfolio. Dimitri Pimbert , Pharmanovia’s V-P, Asia Pacific Region states; “A critical component of our strategy is partnering with like-minded companies who share our purpose and commitment to ensure our medicines get to the patients who need them. That’s why we selected Echo Therapeutics as our partner of choice.” Jude D'Silva D’Silva, Echo Therapeutics ANZ MD added: “This is an important milestone for us. We specialise in promoting important #legacy brands and the #Pharmanovia pain portfolio complements our growing focus on responsible education in managing various types of pain”. “Echo Therapeutics is committed to engaging all its commercial, professional and patient know-how to ensure that Echo’s cross functional teams are able to not only support patients and healthcare professionals, but also to help deliver on business and commercial objectives.” Read the release here👇 #Pharmanovia #EchoTherapeutics #Strategicpartnership #Establishedbrandsgrowth #hospitalpharmaceutical #legacybrands #patientcare

Metric
Company Name	Echo Therapeutics
Symbol
MSH ID	AU:COM:ECHOTHERAPEUTICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals and Medical Devices
Country	AU
Stage	Post-IPO Debt
Employee Count
Website	echotherapeutics.com.au
LinkedIn	echo-therapeutics-pty-ltd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital	1.79M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM

AU:COM:ECHOTHERAPEUTICS

Echo Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue